cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Heron Therapeutics Inc
16 own
32 watching
Current Price
$2.64
$-0.07
(-2.58%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
140.71M
52-Week High
52-Week High
3.22000
52-Week Low
52-Week Low
0.50000
Average Volume
Average Volume
2.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization140.71M
icon52-Week High3.22000
icon52-Week Low0.50000
iconAverage Volume2.31M
iconDividend Yield--
iconP/E Ratio--
What does the Heron Therapeutics Inc do?
Heron Therapeutics, Inc., a biotechnology company, develops products to address unmet medical needs using its proprietary Biochronomer polymer-based drug delivery platform in the United States. Its drug delivery platform is designed to enhance the therapeutic profile of injectable pharmaceuticals. The company's lead product candidate includes SUSTOL (granisetron injection, extended release), which is in Phase III clinical trial for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting. It is also developing HTX-011 that is in Phase I clinical trial for the management of post-operative pain; HTX-019, an injectable neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting; and HTX-003, a formulation of buprenorphine for the management of chronic pain and opioid addiction. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Read More
How much money does Heron Therapeutics Inc make?
News & Events about Heron Therapeutics Inc.
Stock Options Channel
9 months ago
Investors eyeing a purchase of Heron Therapeutics Inc (HRTX) stock, but tentative about paying the going market price of 1.25/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at...
PR Newswire
10 months ago
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer PR Newswire SAN DIEGO, June 12, 2023 SAN DIEGO, June 12, 2023 /PRNewswire/ -- Heron Therapeutics, Inc...
PR Newswire
1 year ago
Heron Therapeutics Announces Commercial Leadership Changes Heron Therapeutics Announces Commercial Leadership Changes PR Newswire SAN DIEGO, April 20, 2023 SAN DIEGO, April 20, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ('Heron'), a commercial-stage biotechnology company...
Fool.com Headlines
1 year ago
The stock has been rising since the company appointed a new CEO.Shares of Heron Therapeutics (NASDAQ: HRTX) were up more than 19% early Thursday afternoon. The biopharmaceutical company, which has been focusing on post-surgery therapeutics, has been on a steady rise since the company announced on ...
PR Newswire
1 year ago
Heron Therapeutics Announces New CEO and Board Chairman Heron Therapeutics Announces New CEO and Board Chairman PR Newswire SAN DIEGO, April 3, 2023 Craig Collard Appointed CEO Adam Morgan Named Chairman of the Board SAN DIEGO, April 3, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ:HRTX...
Frequently Asked Questions
Frequently Asked Questions
What is Heron Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Heron Therapeutics Inc shares?
plus_minus_icon
How can I buy Heron Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Heron Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Heron Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Heron Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Heron Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Heron Therapeutics Inc?
plus_minus_icon
What percentage is Heron Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Heron Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.64
$-0.07
(-2.58%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00